American Association of Clinical Endocrinologists and American Diabetes Association Consensus Statement on Inpatient Glycemic Control
Open accessThe DOI matches its Crossref record; 166 of the 171 references it cites were found in a registry or an index.
Abstract
Does inpatient management of hyperglycemia represent a safety concern? 5. What systems need to be in place to achieve these recommendations?6.Is treatment of inpatient hyperglycemia cost-effective?7. What are the optimal strategies for transition to outpatient care? 8. What are areas for future research? QUESTION 1: DOES IMPROVING GLYCEMIC CONTROL IMPROVE CLINICAL OUTCOMES FOR INPATIENTS WITHHYPERGLYCEMIA? -Hyperglycemia in hospitalized patients, irrespective of its cause, is unequivocally associated with adverse outcomes (5,6,18 -25).Hyperglycemia occurs in patients with known or undiagnosed diabetes, or it occurs during acute illness in those with previously normal glucose tolerance (termed "stress hyperglycemia") (8,26).Intervention directed at reducing blood glucose (BG) levels has resulted in improved outcomes in some, but not all, studies (5,18 -25).Several recent clinical trials in critically ill patients have reported no reduction in mortality from intensive treatment targeting near-euglycemia versus conventional management targeting BG Ͻ180 mg/dl (Ͻ10.0 mmol/l).Of considerable concern are reports of harm, with higher rates of severe hypoglycemia and even increased mortality (14) resulting from intensive glycemic control (12)(13)(14)16,27,28).This variability in results may be attributable to several factors, including differences in intravenous (IV) insulin treatment protocols and their implementation, glycemic targets, patient populations, methods for glucose monitoring, and insulin adjustment (12,29).The following section focuses primarily on results of recent studies with an RCT design that investigated patient outcomes with protocols targeting nearnormalization of BG levels.Readers are referred to a previous ACE position statement (9), an ACE/ADA consensus statement (11), and a technical review (8) for details related to earlier studies supporting inpatient glycemic management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Those without preexisting DM or stress hyperglycemia have a higher incidence of more postheart surgery complications.91,100–103”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [103]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredIn the citing paper
“Glucose targets >180 mg/dL or <110 mg/dL are no longer recommended in ICU patients.”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“and the BG targets used in this study were lower than glycemic targets recently recommended by the AACE and ADA inpatient glycemic control task force.25”
From A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer-guided vs. Standard column-based algorithms (2010) · cites this paper as [25]
In the citing paper
“Many guidelines that apply to hospitalized adults with hyperglycemia can probably be extrapolated to older adults130, 131.”
From Diabetes in Older Adults: A Consensus Report (2012) · cites this paper as [130]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Standards of Medical Care in Diabetes
Power, D. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,673
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 4×
“Nevertheless, recent attempts to achieve tight glycemic control either have not reduced or have actually increased mortality in multicenter trials and clearly led to higher rates of hypoglycemia (13,14,16).”
BackgroundInfluentialIntensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921 · cited 5×
“The higher rates of severe hypoglycemia associated with intensive insulin therapy (12–14,16,27,28) raise the possibility that serious adverse events in the subgroup of patients experiencing hypoglycemia offset, at least in part, any benefit derived from strict glycemic control in the much larger subgroup of patients w…”
BackgroundInfluentialHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationCapes, S. E., Hunt, D., Malmberg, K., & Gerstein, H. C. (2000) · The Lancet · doi:10.1016/s0140-6736(99)08415-9 · Cited by 2,187
Standards of Medical Care in Diabetes—2009
American Diabetes Association (2009) · Diabetes Care · doi:10.2337/dc09-s013 · Cited by 2,167
Bates, D. W. (1998) · JAMA · doi:10.1001/jama.280.15.1311 · Cited by 2,107
The Incidence and Severity of Adverse Events Affecting Patients after Discharge from the Hospital
Forster, A. J., Murff, H. J., Peterson, J. F., Gandhi, T. K., & Bates, D. W. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-3-200302040-00007 · Cited by 1,886 · cited 1×
“Medication errors and adverse drug events have been linked to poor communication of instructions to the patient at the time of discharge (156,157).”
Background
Research works printed but not linked: 5
- 28. Devos P, Preiser JC, Me ´lot C, et al. Im- pact of tight glucose control by intensive insulin therapy on ICU mortality and the rate of hypoglycaemia: final results of the GluControl study (Abstract). Intensive Care Med 2007;33:S189
- 87. Rodbard HW, Blonde L, Braithwaite SS, et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the management of diabetes mellitus. Endocr Pract 2007; 13(Suppl. 1):1-68
- 93. DiNardo M, Donihi AC, DeVita M, et al. A nurse directed protocol for recogni- tion and treatment of hypoglycemia in hospitalized patients. Pract Diabetol 2005;22:37-40
- 97. Donihi AC, Rea RS, Mihalko MA, et al. Comparison of different methods of transitioning MICU patients from intra- venous to subcutaneous insulin (Ab- stract). Diabetes 2007;57:A542
- 117. Reider J, Lin H, Dinardo M, et al. Efficacy of a guideline for treatment of corticoste- roid related hyperglycemia in the hospi- tal (Abstract). Diabetes 2008;57:A574 120.
Cited by
Items 701–800 of 1,001
Chatziravdeli, V., Lambrou, G. Ι., Samartzi, A., Kotsalas, N., Vlachou, E. D., Komninos, J., & Tsartsalis, A. N. (2023) · Medicina · doi:10.3390/medicina59010141 · Cited by 9
“Current guidelines suggest the use of insulin as basal bolus or continuous subcutaneous insulin infusion (CSII) in Type 1 diabetes mellitus (T1DM) and for hospitalized patients [4].”
BackgroundRushakoff, R. J., Sullivan, M. M., Seley, J. J., Sadhu, A., O’Malley, C. W., Manchester, C. S., Peterson, E. D., & Rogers, K. M. (2014) · Healthcare · doi:10.1016/j.hjdsi.2014.06.004 · Cited by 9
Tanner, J. M., Chang, T. I., Harada, N. D., Santiago, S., Weinreb, J. E., & Friedlander, A. H. (2011) · Journal of Oral and Maxillofacial Surgery · doi:10.1016/j.joms.2011.01.012 · Cited by 9
Inpatient hyperglycemia: Clinical management needs in teaching hospital
Tamez-Pérez, H. E., Quintanilla-Flores, D. L., Peña, S. L. P., González‐González, J. G., Hernández-Coria, M. I., Garza‐Garza, L. A., & Tamez-Peña, A. L. (2014) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2014.09.004 · Cited by 9
“We found that most hyperglycemic patients received insulin as suggested by most published guidelines [14].”
BackgroundFisk, L., Compte, A. J. L., Shaw, G. M., & Chase, J. G. (2012) · Journal of Healthcare Engineering · doi:10.1260/2040-2295.3.3.415 · Cited by 9
“However, despite these potential benefits, the risk of hypoglycemia and worsened outcome [2, 12] is seen as a major barrier to widespread adoption of accurate glycemic control, with higher BG preferred due to reduced risk of iatrogenic hypoglycemia [13].”
BackgroundInpatient management of type 2 Diabetes Mellitus: Does choice of insulin regimen really matter?
Akhtar, S. T., Mahmood, K., Naqvi, I. H., & Vaswani, A. S. (2014) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.304.4920 · Cited by 9
Effects of different tube types on patient classification using current diabetes decision limits
Orth, M., Hawran, H., Ulloor, J., Bachhawat, K., & Lennartz, L. (2019) · Practical Laboratory Medicine · doi:10.1016/j.plabm.2019.e00134 · Cited by 9
Individualizing Glycemic Control in the Critically Ill
Murphy, C. V., Saliba, L., MacDermott, J., Soe, K. K., & Dungan, K. M. (2019) · Critical Care Nursing Quarterly · doi:10.1097/cnq.0000000000000288 · Cited by 9
Mithal, A., Sharma, J., Kulkarni, A. P., Sivakumar, M., Mehta, Y. B., Chakravarti, S., Joshi, A., Reddy, B. R., & Bathina, H. (2019) · Indian Journal of Critical Care Medicine · doi:10.5005/jp-journals-10071-23298 · Cited by 9
The impact of diabetology consultations on length of stay in hospitalized patients with diabetes
Sheahan, K. H., Atherly, A. J., Dayman, C., & Schnure, J. J. (2020) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.199 · Cited by 9
Perioperative Management of the Patient with Diabetes Mellitus
Schroeder, S. M. (2013) · Clinics in Podiatric Medicine and Surgery · doi:10.1016/j.cpm.2013.10.002 · Cited by 9
Glycated hemoglobin A: A predictor of outcome in trauma admissions to intensive care unit
John, J. K., Lionel, K. R., & Sen, N. (2014) · Indian Journal of Critical Care Medicine · doi:10.4103/0972-5229.125431 · Cited by 9
Raurell‐Torredà, M., Perez, E. C., Aragon, M. D., Ribe, R. M., Juvanteny, E. P., & Boreu, Q. F. (2011) · American Journal of Critical Care · doi:10.4037/ajcc2011117 · Cited by 9
“ation in their consensus statement on inpatient glycemic control.(18) Our findings concur with results of other studies”
BackgroundResultPichardo-Lowden, A. R., Farbaniec, M., & Haidet, P. (2018) · Journal of Evaluation in Clinical Practice · doi:10.1111/jep.13057 · Cited by 9
“The limited preparedness observed in the study occurred in the following domains: (1) knowledge about details of diabetes or glycemic status of patients; (2) preparation and participation of trainees at different levels of training in discussion during rounds; (3) interest in diabetes and glucose management among prov…”
BackgroundMethodResultInfluentialKhoury, G. E., Mansour, H., Kabbara, W. K., Chamoun, N. R., Atallah, N., & Salameh, P. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666180119142254 · Cited by 9
Lovig, K. O., Horwitz, L. I., Lipska, K. J., Kosiborod, M., Krumholz, H. M., & Inzucchi, S. E. (2012) · The Joint Commission Journal on Quality and Patient Safety · doi:10.1016/s1553-7250(12)38051-3 · Cited by 9
Self-citationCornell, S. A. (2010) · Health Policy · doi:10.1016/j.healthpol.2010.02.006 · Cited by 9
Hypoglycemia Rates After Restriction of High-Dose Glargine in Hospitalized Patients
Lee, S. Y., Askin, G., McDonnell, M. E., Arnold, L. M., & Alexanian, S. M. (2016) · Endocrine Practice · doi:10.4158/ep161288.or · Cited by 8
Preoperative Optimization of Patients Undergoing Ambulatory Surgery
Fong, R., & Sweitzer, B. J. (2014) · Current anesthesiology reports · doi:10.1007/s40140-014-0082-5 · Cited by 8
“To date, there is insufficient evidence to establish a specific HgA1c cutoff to allow a patient to proceed with ambulatory surgery; although a review documenting an increased rate of adverse perioperative outcomes associated with HgA1c [ 7 % (which incidentally corresponds to the ADA recommended target for outpatient…”
BackgroundDraznin, B., Wang, Y., Seggelke, S. A., Hawkins, R. M., Gibbs, J., Bridenstine, M., Rasouli, N., & Wang, C. L. (2014) · Endocrine Practice · doi:10.4158/ep14174.or · Cited by 8
Liu, G., Dou, J., Pan, Y., Yan, Y., Zhu, H., Lu, J., Gaisano, H. Y., Ji, L., & He, Y. L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00639 · Cited by 8
“Some clinical guidelines recommended a basal insulin regimen as the initiation insulin therapy for hyperglycemia in non-critically ill patients (10, 12), whereas a premixed insulin formulation is also a most frequently prescribed treatment for patients with T2DM in many regions in Asia, Europe, and Latin America (8, 9…”
BackgroundManagement of Inpatient Hyperglycemia and Diabetes in Older Adults
Davis, G. M., DeCarlo, K., Wallia, A., Umpierrez, G. E., & Pasquel, F. J. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.008 · Cited by 8
Self-citationRayyan‐Assi, H., Feldman, B., Leventer‐Roberts, M., Akriv, A., & Raz, I. (2020) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3420 · Cited by 8
“Three sensitivity analyses were also conducted to examine the robustness of the association between stress hyperglycaemia and mortality: (1) We excluded members with a trauma‐related hospitalization or attended an ICU during their inpatient stay, as an attempt to minimize the severest cases among the study population;…”
BackgroundMethodInfluentialMeyerov, J., Louis, M., Lee, D. K., Fletcher, L. R., Banyasz, D., Miles, L. F., Ma, R., Tosif, S., Koshy, A. N., Story, D., et al. (2021) · BJS Open · doi:10.1093/bjsopen/zraa070 · Cited by 8
Addendum 1: Forum for Injection Technique and Therapy Expert Recommendations, India
Kalra, S., Unnikrishnan, A., KUMAR, K. M. P., Sahay, R. K., Chandalia, H. B., Saboo, B., Sundaram, A., Kesavadev, J., Shukla, R., WANGNOO, S. K., et al. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01332-x · Cited by 8
Association of persistent postoperative hyperglycemia with mortality after elective craniotomy
He, J., Zhang, Y., Jia, L., Cheng, X., Tian, Y., Hao, P., Li, T., Xiao, Y., Peng, L., Feng, Y., et al. (2023) · Journal of neurosurgery · doi:10.3171/2023.7.jns23777 · Cited by 8
Mutailifu, S., Zhu, Q., Cai, X., Heizhati, M., Liu, S., Dang, Y., Wu, T. F., Hong, J., Lin, Y., & Li, N. (2024) · Journal of International Medical Research · doi:10.1177/03000605241291742 · Cited by 8
“29,30 To effectively manage hyperglycaemia in critically ill patients admitted to the intensive care unit, it is recommended to utilize intravenous insulin instead of oral hypoglycaemic agents.”
Barriers to Implementing an Insulin Order Form In a Non-ICU Medical Unit.
Arif, S. A., & Escaño, A. K. (2010) · PubMed · Cited by 8
Effectively Identifying the Inpatient With Hyperglycemia to Increase Patient Care and Lower Costs
Mabrey, M., McFarland, R., Young, S. L., Cooper, P. L., Chidester, P., & Rhinehart, A. S. (2014) · Hospital Practice · doi:10.3810/hp.2014.04.1098 · Cited by 8
Kim, S., Rushakoff, R. J., Sullivan, M. M., & MacMaster, H. W. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600622 · Cited by 8
Higgs, M., & Fernandez, R. S. (2016) · Intensive and Critical Care Nursing · doi:10.1016/j.iccn.2016.08.007 · Cited by 8
Caimari, F., González, C., Ramos, A., Chico, A. I., Cubero, J. M., & Pérez, A. (2015) · Cirugía Española · doi:10.1016/j.ciresp.2015.02.007 · Cited by 9
Davis, S., Friece, C., Roderman, N. S., Newcomer, D., & Castaneda, E. (2017) · Pharmacy · doi:10.3390/pharmacy5020022 · Cited by 8
“The American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) consensus statement on inpatient glycemic control defines severe hypoglycemia as a blood glucose level less than 40 mg/dL, hypoglycemia as a blood glucose level less than 70 mg/dL, and hyperglycemia as a blood gluc…”
BackgroundInfluentialManagement of hyperglycemia in the neurosurgery patient
Daniel, R., Villuri, S., & Furlong, K. (2017) · Hospital Practice · doi:10.1080/21548331.2017.1370968 · Cited by 8
“Re Oral Stop [25] Basal insulin (long acting, one dose daily) Basal insulin (split dose) Full dose Decrease to 60–87% dose Full dose the night, decrease as above in am [12,26,24]”
BackgroundBrand, D. A., Peragallo‐Dittko, V., Fazzari, M. J., Islam, S., Jacobson, A. M., & Radin, M. S. (2019) · Endocrine Practice · doi:10.4158/ep-2018-0498 · Cited by 8
Savoury cracker development for blood glucose control and management
Qi, X., Ta, M. N., & Tester, R. F. (2020) · Bioactive Carbohydrates and Dietary Fibre · doi:10.1016/j.bcdf.2020.100249 · Cited by 8
Outcomes and adverse effects of extremely high dose insulin infusions in ICU patients
Vidger, A. J., & Czosnowski, Q. A. (2021) · Journal of Critical Care · doi:10.1016/j.jcrc.2021.01.015 · Cited by 8
COVID-19 y diabetes mellitus. Importancia del control glucémico
Alonso, N., & Batule, S. (2021) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/j.arteri.2021.05.001 · Cited by 8
Goyal, A., Mathew, U. E., Golla, K. K., Mannar, V., Kubihal, S., Gupta, Y., & Tandon, N. (2021) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2021.102244 · Cited by 8
Prognostic value of glycemic gap in patients with spontaneous intracerebral hemorrhage
Wang, C., Wang, W., Li, G., Wang, A., Zhang, X., Xiong, Y., & Zhao, X. (2022) · European Journal of Neurology · doi:10.1111/ene.15432 · Cited by 8
Woo, S., Nah, S., Kim, M., Kim, S., Lee, D., Moon, J. E., & Han, S. (2022) · Children · doi:10.3390/children9111741 · Cited by 8
“The following data were extracted: age of first unprovoked seizure [16], sex, relevant medical history (birth details, neonatal intensive care unit admission, and family history), number of seizures within the 24 h after the first presentation [17], seizure duration [18], focal manifestations such as Todd’s paralysis,…”
MethodThe Impact of Inpatient Point-Of-Care Blood Glucose Quality Control Testing
Corl, D. E., Yin, T. S., Hoofnagle, A. N., Whitney, J. D., Hirsch, I. B., & Wisse, B. E. (2011) · Journal for Healthcare Quality · doi:10.1111/j.1945-1474.2012.00149.x · Cited by 8
“…may be limited until more stringent standards are adopted for meter precision and test strip quality—changes that have been recommended for decades (Moghissi et al., 2009; Boyd & Bruns, 2001; Hirsch et al., 2008; Westgard et al., 1974) including again at a recent FDA hearing (Food and Drug…”
BackgroundSelf-citationControl glucémico en el enfermo crítico: comparación de dos protocolos de insulinización intravenosa
Raurell‐Torredà, M., Serrano, C. D. L., Almirall-Solsona, D., Catalán-Ibars, R. M., & Arfelis, J. M. N. (2013) · Medicina Clínica · doi:10.1016/j.medcli.2012.11.032 · Cited by 8
Improving IV Insulin Administration in a Community Hospital
Magee, M. C. (2012) · Journal of Visualized Experiments · doi:10.3791/3705 · Cited by 8
Addressing Glycemic Targets from Diagnosis to Discharge
Malaskovitz, J., & Hodge, C. (2014) · Diabetes Spectrum · doi:10.2337/diaspect.27.3.169 · Cited by 8
Medanta insulin protocols in patients undergoing cardiac surgery
Bansal, B., Mithal, A., Carvalho, P., Mehta, Y. B., & Trehan, N. K. (2014) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/2230-8210.137486 · Cited by 8
“[21] However, this statement is further qualified that, lower BG can be targeted in select group of patients.”
The potential role of incretin therapy in the hospital setting
Macdonald, J. J., Neupane, S., & Gianchandani, R. Y. (2015) · Clinical Diabetes and Endocrinology · doi:10.1186/s40842-015-0005-5 · Cited by 8
“0/ A wealth of clinical experience using insulin in the inpatient setting exists, where it remains the preferred method of glycemic control [5, 9].”
BackgroundTime-dependent glycemic variability and mortality in critically ill patients with diabetes*
Umpierrez, G. E., & Smiley, D. D. (2010) · Critical Care Medicine · doi:10.1097/ccm.0b013e318202e7c0 · Cited by 8
Self-citationPrävention der postoperativen Wundinfektion: Zwischen Tradition und Evidenz
Scheithauer, S., Artelt, T., Bauer, M., & Waeschle, R. M. (2016) · Der Anaesthesist · doi:10.1007/s00101-016-0169-0 · Cited by 8
Perioperative Management of the Diabetic Patient
Soldevila, B., Lucas, A., Zavala, R., & Mauricio, D. (2016) · Springer eBooks · doi:10.1007/978-3-319-28821-5_8 · Cited by 8
Lutz, M. F., Haines, S. T., Lesch, C. A., & Szumita, P. M. (2016) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp160417 · Cited by 8
Intravenous insulin use: technical aspects and caveats.
Kalra, S., & Bajwa, S. S. (2013) · PubMed · Cited by 8
Núñez-Patiño, R. A., Vaca, A. Z., & Rivera‐Lara, L. (2018) · Brain Injury · doi:10.1080/02699052.2018.1457181 · Cited by 8
“Accessed June 11, 2017) propose that glycaemic control infusions should aim to maintain BG levels less than 200 mg/dL in neurocritically ill patients with hyperglycaemia (31).”
BackgroundKooshki, A., Khazaei, Z., Rad, M., Zarghi, A., & Mogaddam, A. C. (2018) · Biomedical Research and Therapy · doi:10.15419/bmrat.v5i9.476 · Cited by 8
Kang, R., Han, S., Kim, J. M., Lee, K. W., Park, H. W., Ahn, J., Kim, S., Kang, E., Kim, G. S., & Joh, J. (2019) · Transplant International · doi:10.1111/tri.13496 · Cited by 8
Con: Tight Perioperative Glycemic Control
Floyd, T. F., & Horák, J. V. (2009) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2009.08.008 · Cited by 8
Risk-Based Care: Let's Think Outside the Box
Chase, J. G., Shaw, G. M., Preiser, J., Knopp, J. L., & Desaive, T. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.535244 · Cited by 7
“Beyond potential benefit and the high difficulty in providing safe, effective GC for all patients (9–11), the risk of hypoglycemia—a potentially catastrophic event in terms of outcome risk of death (12–16)—is offset by the risk of permissive hyperglycemia from higher targets (17) and associated glycemic variability (1…”
BackgroundTienstra, M., de Boer, J., van Doesum, J. A., Keijzer, K., Morsink, L. M., Hazenberg, C. L. E., Ammatuna, E., Huls, G. A., Choudhary, P., Gans, R. O. B., et al. (2024) · Endocrine Practice · doi:10.1016/j.eprac.2024.09.013 · Cited by 7
“%) were male, the median age was 64 (IQR [58-68]) years and median body mass index (BMI) was 25.1 kg/m 2 (IQR [23-27]). r Six (10”
BackgroundInfluentialZhao, S., Fu, D., Luo, W., Shen, W., Miao, X.-M., Li, J., Yu, J., Zhao, Q., Li, H., & Dai, R. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02468-9 · Cited by 7
“Furthermore, blood glucose levels above 140 mg/ dL are commonly used to define mild hyperglycemia across various clinical settings [52, 53].”
BackgroundBajwa, S. J., Baruah, M., Kalra, S., & Kapoor, M. (2015) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/0970-9185.155141 · Cited by 7
Manejo de la hiperglucemia en el paciente hospitalizado no crítico con alimentación oral
Jansen, S., Buonaiuto, V. A., Márquez-Gómez, I., & Gómez‐Huelgas, R. (2011) · Revista Clínica Española · doi:10.1016/j.rce.2011.05.014 · Cited by 7
Archer, J. R. H., Misra, S., Simmgen, M., Jones, P. W., & Baker, E. H. (2011) · BMJ Open · doi:10.1136/bmjopen-2011-000210 · Cited by 7
Therapeutic Targets of Glutamine in Parenteral Nutrition: A Medical Science Review
Leguina‐Ruzzi, A. (2015) · International Journal of Prevention and Treatment of Substance Use Disorders · Cited by 7
Moyer, E. D., Lehman, E. B., Bolton, M., Goldstein, J., & Pichardo-Lowden, A. R. (2021) · Scientific Reports · doi:10.1038/s41598-021-89945-3 · Cited by 7
Evidence-based therapeutics for hyperglycemia in hospitalized noncritically ill patients
Gracia‐Ramos, A. E., Carretero‐Gómez, J., Mendez, C. E., & Carrasco-Sánchez, F. J. (2021) · Current Medical Research and Opinion · doi:10.1080/03007995.2021.1997288 · Cited by 7
Wongtanasarasin, W., Ungrungseesopon, N., & Phinyo, P. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11113067 · Cited by 7
“According to the American Diabetes Association (ADA) and American Association of Clinical Endocrinologists (AACE) task force on inpatient glycemic control [20], a glucose level between 140 and 180 mg/dL has been recommended for the ICU patients [21].”
BackgroundGlucometrics: Where Are We Now?
Engle, K., Bacani, G., Cook, C. B., Maynard, G. A., Messler, J., & Kulasa, K. M. (2023) · Current Diabetes Reports · doi:10.1007/s11892-023-01507-1 · Cited by 7
Updates on the Management of Hyperglycemia in Hospitalized Adult Patients
Razavi, L., & Omoregie, C. (2023) · Endocrines · doi:10.3390/endocrines4030037 · Cited by 7
“It has been shown that hyperglycemia in hospitalized patients is associated with an increased risk of complications, mortality, a higher rate of admission to ICUs, and a higher need to transition to rehabilitation facilities after discharge [19,20].”
BackgroundInfluentialAronson, D., & Edelman, E. R. (2012) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.01.011 · Cited by 7
Caimari, F., González, C., Ramos, A., Chico, A. I., Cubero, J. M., & Pérez, A. (2016) · Cirugía Española (English Edition) · doi:10.1016/j.cireng.2016.08.001 · Cited by 7
Reducing admissions for people with diabetes.
Allan, B. J. (2014) · PubMed · Cited by 7
Challenges With Insulin in the Inpatient Setting
Kolanczyk, D. M., & Dobersztyn, R. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.3.146 · Cited by 7
“Close follow-up also should be arranged with a primary care provider, endocrinologist, or diabetes educator no later than 1 month after discharge, especially for patients newly initiated on insulin (3,17).”
BackgroundInfluentialA Primer on Diabetes Mellitus: Foundations for the Incoming First-Year Resident
Amori, R. E., & Simon, B. F. (2016) · MedEdPORTAL · doi:10.15766/mep_2374-8265.10469 · Cited by 7
Cardiovascular Safety of Antidiabetic Drugs in the Hospital Setting
Seggelke, S. A., Lindsay, M. C., Hazlett, I., Sanagorski, R., Eckel, R. H., & Wang, C. C. L. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0884-1 · Cited by 7
The comparison of two glucose measurement systems: POCT devices versus central laboratory
Baygutalp, N. K., Bakan, E., Bayraktutan, Z., & Umudum, F. Z. (2018) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2017-0196 · Cited by 7
“The statistical evaluation of the results has shown that GLU results comparable with the laboratory method were observed for the majority of the glucose meters used in the hospital and that the performance of these devices is better in prediabetic (from 100 to 125 mg/dL) and in hyperglycemic (>126 mg/dL) GLU levels as…”
ResultRamos, A., Rabasa, F., Mendoza, L. C., Cardenete, J., Gill, P., Morilla, A., Cardona, D., & Pérez, A. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0433-1 · Cited by 7
“Both the consensus statement by the American Diabetes Association (ADA) and the American Association of Clinical Endocrinologists (AACE) as well the clinical practice guideline of the Endocrine Society recommend a premeal BG level\140 mg/dl and random BG values\ 180 mg/dl [12, 13].”
BackgroundInfluentialImpact of insulin on the intestinal microcirculation in a model of sepsis-related hyperglycemia
Caldwell, A., Morick, J. N., Jentsch, A.-M., Wegner, A., Pavlović, D., Al-Banna, N., & Lehmann, C. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.05.004 · Cited by 7
D’Souza, S., & Kruger, D. F. (2020) · Diabetes Therapy · doi:10.1007/s13300-020-00920-z · Cited by 7
Pragmatic review of interventions to prevent inpatient hypoglycaemia
Gray, J., Roseleur, J., Edney, L. C., & Karnon, J. D. (2021) · Diabetic Medicine · doi:10.1111/dme.14737 · Cited by 7
Manejo óptimo de la glucemia en el paciente neurocrítico
Godoy, D. A., Rabinstein, A. A., Videtta, W., & Cabezas, F. M. (2010) · Revista de Neurología · doi:10.33588/rn.5112.2009499 · Cited by 7
Glucose Disturbances and Atypical Antipsychotic Use in the Intensive Care Unit
Bishara, A., Phan, S. V., Young, H. N., & Liao, T. V. (2015) · Journal of Pharmacy Practice · doi:10.1177/0897190015579452 · Cited by 7
“Although a wide range of metabolic disturbances have been associated with atypical antipsychotic medications, glucose dysregulation is particularly important, as hyperglycemia from any cause is associated with increased mortality and morbidity in the critically ill population.(21,25,26) The exact prevalence of hypergl…”
BackgroundGlycemic control during labor and delivery: a survey of academic centers in the United States
Grant, E. N., & Joshi, G. P. (2011) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-011-1972-0 · Cited by 7
“One of the reasons for this variation may be the conXict between the ACOG recommendations that were primarily based upon the position statement of the ACE [8] and the recent American Association of Clinical Endocrinologists (AACE) and the American Diabetes Association (ADA) recommendation for a target BGL of 140–180 m…”
BackgroundMethodManejo da hiperglicemia no paciente hospitalizado não crítico
Leal, C. L., Pisi, P. C. B., de Figueiredo, A. B., de Almeida, S. C. L., & Moriguti, J. C. (2010) · Medicina (Ribeirão Preto) · doi:10.11606/issn.2176-7262.v43i2p134-142 · Cited by 7
Clinical Nurse Specialists Lead Teams to Impact Glycemic Control After Cardiac Surgery
Klinkner, G., & Murray, M. (2014) · Clinical Nurse Specialist · doi:10.1097/nur.0000000000000056 · Cited by 7
Ogawa, S., Nako, K., Okamura, M., Senda, M., Sakamoto, T., & Ito, S. (2013) · Journal of Diabetes Mellitus · doi:10.4236/jdm.2013.34037 · Cited by 7
Hyperglycemia in nondiabetic patients during the acute phase of stroke
Godoy, D. A., Morejón, C. D. D. S., Videtta, W., Fuenzalida, L. C., Paranhos, J., Costilla, M., Piñero, G., Jibaja, M., & de Melo, L. J. V. (2012) · Arquivos de Neuro-Psiquiatria · doi:10.1590/s0004-282x2012000200012 · Cited by 7
Thabit, H., Kumareswaran, K., Haidar, A., Leelarathna, L., Caldwell, K., Elleri, D., Allen, J. M., Nodale, M., Wilinska, M. E., Jackson, N. C., et al. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4519 · Cited by 7
Pearson, K. K., Reiland, S. A., Meara, J. G. O., Brown, J. K., Fedraw, L. A., & Mapes, D. L. (2016) · Journal for Healthcare Quality · doi:10.1097/jhq.0000000000000004 · Cited by 7
“Risks associated with neglecting glycemic control are great in the hospital (Moghissi et al., 2009).”
BackgroundWhat Can We Learn From Point-of-Care Blood Glucose Values Deleted and Repeated by Nurses?
Corl, D. E., Yin, T. S., Ulibarri, M., Lien, H., Tylee, T. S., Chao, J. H., & Wisse, B. E. (2018) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818763891 · Cited by 7
Peterson, E. D., Sloan, M. A., Whitlow, P. L., Krumholz, H. M., Morrison, D. A., Ornato, J. P., Casey, D. E., Green, L. A., Hochman, J. S., Antman, E. M., et al. (2009) · Cited by 7
Bell, K. F., Parasuraman, S. V., Raju, A., Shah, M. B., Graham, J., & Denno, M. S. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.3.220 · Cited by 7
“In addition, fear of hypoglycemia can lead to medication noncompliance and failure to achieve glycemic control.(12,15) Given the similarities between the effects of oral and insulin-containing antidiabetic therapies on glycemic control and the risk of hypoglycemia with insulin, there is a need to assess the impact of…”
BackgroundЮрьева, М. Ю., & Dvoryashina, I. V. (2017) · Kardiologiia · doi:10.18087/cardio.2403 · Cited by 7
“ентов в период декомпенсации ХСН, потребовавшей госпитализации в стационар [53].”
Gupta, T., & Hudson, M. (2017) · Journal of the Endocrine Society · doi:10.1210/js.2016-1055 · Cited by 7
Rodríguez-Calero, M. Á., Llodrá, E. B., Cuberos, M. C., Blanco‐Mavillard, I., & Axartell, M. A. P. (2019) · Enfermería Intensiva (English ed ) · doi:10.1016/j.enfie.2018.01.004 · Cited by 7
“To respond to these many factors, nurse-led protocols have focussed on training, raising the awareness of and strengthening the nursing team in decision-making and managing complex clinical situations to maintain target glycaemia levels, generally supported by computer tools or insulin dosage calculators.(12,29) This…”
BackgroundVongsumran, N., Buranapin, S., & Manosroi, W. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s262444 · Cited by 7
Trialogue. La gestione dell’iperglicemia in area medica. Istruzioni per l’uso
Beltramello, G., Manicardi, V., & Trevisan, R. (2012) · Italian Journal of Medicine · doi:10.4081/itjm.2012.123 · Cited by 7
Control glicémico de pacientes diabéticos hospitalizados en un Servicio de Medicina Interna
Solís, I., Hurtado-Hurtado, N., Demangel, D., Cortés, C. P., & Néstor Soto, I. (2012) · Revista médica de Chile · doi:10.4067/s0034-98872012000100009 · Cited by 7
Smith, L. G., Mendoza, N., DOBESH, D. P., & Smith, S. M. (2021) · medRxiv · doi:10.1101/2021.05.28.21258012 · Cited by 7
“Confirming prior results on hospitalized Covid patients , obesity was more common and more severe in younger patients in this Cohort (11).”
MethodResultThe impact of poor post-operative glucose control on neurosurgical surgical site infections (SSI)
Weber, T., Ge, B., Tanaka, T., & Litofsky, N. S. (2021) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2021.08.024 · Cited by 6
A Retrospective Cohort Analysis of Two Computerized Insulin Infusion Protocols
Lalani, B., Gosselin, K. P., Penno, R., Puryear, B., Rilo, H., & Lalani, A. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231163584 · Cited by 6
“8 This project pays particular attention to a new, but now familiar, subset of patients: COVID-19 ICU patients.”
Background
Metadata
- Authors
- Moghissi, E. S., Korytkowski, M. T., DiNardo, M., Einhorn, D., Hellman, R., Hirsch, I. B., Inzucchi, S. E., Ismail-Beigi, F., Kirkman, M. S., & Umpierrez, G. E.
- Affiliations
- University of California, Los Angeles (US)
- University of Pittsburgh (US)
- University of California San Diego (US)
- University of Missouri–Kansas City (US)
- University of Washington (US)
- Yale New Haven Hospital (US)
- Department of Medicine, Physiology and Biophysics, Division of Clinical and Molecular Endocrinology, Case Western Reserve University, Cleveland, Ohio;
- American Diabetes Association (US)
- Emory University (US)
- Corresponding author
- Moghissi, Etie S.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-06-01
- Volume
- 32
- Issue
- 6
- Pages
- 1119-1131
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2681039
- OpenAlex
- W2149347361
- Cited by
- 1,444
- References
- 171
- Citations by year
- 2026: 23 · 2025: 48 · 2024: 78 · 2023: 63 · 2022: 66 · 2021: 83 · 2020: 98 · 2019: 67 · 2018: 84 · 2017: 85 · 2016: 101 · 2015: 105 · 2014: 134 · 2013: 89 · 2012: 131
- FWCI
- 76.48
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- inpatient glycemic control, hyperglycemia, stress hyperglycemia, intensive insulin therapy, hypoglycemia, critically ill patients, hospitalized patients, transition to outpatient care, cost-effectiveness, glucose monitoring, clinical outcomes
- MeSH terms
- Blood Glucose, Consensus Statements as Topic, Diabetes Mellitus, Endocrinology, Humans, Hyperglycemia, Inpatients, Societies, Medical
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.